A Clinical Study of T3011 in Subjects With Advanced Melanoma
Clinical trial NCT06214156 · RECRUITING
Trial details
- NCT number
- NCT06214156
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-26
- Primary completion
- 2026-09-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.